Cart
0

World STDs Diagnosis Market - Opportunities and Forecasts, 2017-2023

Get 20% Free Customization In This Report
LI_18433
Pages: NA
Oct 2018 | 987 Views
 
Author's : NA
Tables: NA
Charts: NA
 

Sexually transmitted diseases spread through sexual contact. The cause of these diseases may be bacterial, fungal, viral or protozoa infections. The major types of these diseases include Chlamydia, herpes, human papillomavirus (HPV), Gonorrhea, Syphilis, Trichomoniasis and HIV. Testing of STDs include single infection test or it may include number of tests for range of infections. The different tests include diagnostic test, screening test, contact tracing and epidemiological surveillance. These tests are delivered in the laboratories or at the Point-of-Care (POC). A pin-point analysis of the global market for STDs diagnosis focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities. The competitive landscape section focuses on key leaders within the global market for STDs diagnosis and their major growth strategies. A deep-dive assessment of segments identifies potential segments, which would act as a guide for strategists. 

Untreated STDs such as Chlamydia, develop pelvic inflammatory disease among woman, which may further lead to infertility. Majority of the cervical cancers in woman originates from HPV infections and contributes to one of the leading causes of death due to cervical cancer. Globally, high incidence of STDs is the prime driver for this market. Additionally, government induced national screening programs and favorable reimbursement strategies heighten the market growth. Despite of diagnostic testing availability, the global STD testing market finds impediments due to the stigma associated with the testing. Also, hurdles and setbacks are witnessed in the growth of STD testing market due to critical regulatory compliance and widespread diseases in remote areas. Laboratory testing is the reliable method of diagnosis and it could be benefited by the national screening programs in the respective regions. Asia-pacific market provides the niche opportunity for POC testing due to government support and rising healthcare awareness.

Global Market for STDs Diagnosis by Type

The global market for STD diagnosis is segmented based on STD types and include Gonorrhea testing, Human Papilloma Virus (HPV) testing, Chlamydia testing, Chancroid testing, Herpes Simplex Virus (HSV) testing, P&S Syphilis testing &  Human Immunodeficiency Virus (HIV) testing. Chlamydia, P&S Syphilis and Gonorrhea have high prevalence, globally. Majority of the cervical cancer related deaths occurs due to HPV infection. Undiagnosed and untreated Syphilis is the prime reason for Congenital Syphilis and lead to preterm labor associated with many complications.

Global Market for STDs Diagnosis by Location

On the basis of location, the global market for STDs diagnosis is categorized into Point-Of-Care (POC) Testing and Laboratory Testing. POC tests do not identify all STDs and many of these methods don’t follow the standard regulatory norms. Hence, laboratory methods are highly significant and reliable. 

Global Market for STDs Diagnosis by Geography

Geographically, global market for STD diagnosis is segmented into North America, Europe, Asia-Pacific and LAMEA. North America and Europe has high prevalence of Chlamydia, P&S Syphilis and Gonorrhea and holds the largest share for testing of these infections. Chancroid is almost non-existent in developed regions. Asia-Pacific dominates the market for the testing of HIV, Chancroid and HSV. 

Competitive Landscape

The key players within global market for STD diagnosis include Becton, Dickinson, Roche Diagnostics, Biomerieux SA, Gen-Probe Inc., Beckman Coulter, Inc., and Alere. STD testing market has few market players and most of them focus on developing new testing methods for diagnosis of range of STDs. Development of accurate and reliable method that would comply with regulatory guidelines is the major opportunity for market players.

High Level Analysis  

A comprehensive analysis of the global market for STD diagnosis provides an overview of the market and its key concerns. The market dynamics section covers market drivers, restraints and opportunities within the global market for STD diagnosis and helps in simplifying market behavior. The market is segmented in order to provide   information about niche market areas and assists in identifying potential segments. Porter’s Five Forces analysis enables the determination of profitable markets. Suppliers of this market have high bargaining power due to their limited number in comparison with large pool of population suffering from STDs. National screening programs and government initiatives have supported new players to enter the market, whereas critical regulatory compliance limits their entry into the market. Due to this fact, the threat from new entrants is moderate. Industrial rivalry is moderate due to few market players, which would become intense in the near future due to government support programs for STD testing.

KEY BENEFITS

  • This report offers the following benefits in particular:
  • In-depth coverage of the global market for STD diagnosis including drivers, restraints and opportunities would help professionals better understand market behavior  
  • Pin-point analysis of geographic segments helps to identify opportunities for growth within the global market for STD diagnosis
  • Porter’s Five Forces analysis examines the competitive structure of the global market for STD diagnosis and would assist market strategists 
  • Detailed study of the strategies of key leaders, partnerships and acquisitions in the global market for STD diagnosis would be informative for professionals in the corporate sector 
  • The market estimates provided in the report would be informative to market players to define their future strategies   

KEY DELIVERABLES

The global market for STD diagnosis is segmented into three major categories such as type, location and geography. 

MARKET BY TYPE

  • Gonorrhea Testing 
  • Human Papilloma Virus (HPV) Testing
  • Chlamydia Testing
  • Chancroid Testing
  • Herpes Simplex Virus (HSV) Testing
  • P&S Syphilis Testing
  • Human Immunodeficiency Virus (HIV) Testing

MARKET BY LOCATION

  • Point-Of-Care (POC) Testing
  • Laboratory Testing

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

Chapter: 4 STDS DIAGNOSIS MARKET, BY DISEASE TYPE

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. CHLAMYDIA
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast by region
4.2.3. Market size and forecast by country
4.3. P&S SYPHILIS
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast by region
4.3.3. Market size and forecast by country
4.4. GONORRHEA
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast by region
4.4.3. Market size and forecast by country
4.5. HERPES SIMPLEX VIRUS (HSV)
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast by region
4.5.3. Market size and forecast by country
4.6. HUMAN PAPILLOMA VIRUS (HPV)
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast by region
4.6.3. Market size and forecast by country
4.7. HUMAN IMMUNODEFICIENCY VIRUS (HIV)
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast by region
4.7.3. Market size and forecast by country
4.8. CHANCROID
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast by region
4.8.3. Market size and forecast by country

Chapter: 5 STDS DIAGNOSIS MARKET, BY LOCATION OF DIAGNOSIS

5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. LABORATORY
5.2.1. Market size and forecast by region
5.2.2. Market size and forecast by country
5.3. POINT-OF-CARE (POC) DIAGNOSIS
5.3.1. Market size and forecast by region
5.3.2. Market size and forecast by country

Chapter: 6 STDS DIAGNOSIS MARKET, BY DEVICE TYPE

6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. LABORATORY DEVICES
6.2.1. Market size and forecast by region
6.2.2. Market size and forecast by country
6.2.3. Market size and forecast by type
6.2.3.1. PCRs
6.2.3.1.1. Market size and forecast
6.2.3.2. Immunochromatographic capillary flow dipstick technology (Assay)
6.2.3.2.1. Market size and forecast
6.2.3.3. Flow Cytometers
6.2.3.3.1. Market size and forecast
6.2.3.4. Differential Light Scattering
6.2.3.4.1. Market size and forecast
6.2.3.5. Enzyme Linked Immunosorbent Assay (ELISA)
6.2.3.5.1. Market size and forecast
6.3. POC DEVICES
6.3.1. Market size and forecast by region
6.3.2. Market size and forecast by country
6.3.3. Market size and forecast by type
6.3.3.1. Phone chips (microfluidics + ICT)
6.3.3.1.1. Market size and forecast
6.3.3.2. Portable / bench top / rapid diagnostic kits
6.3.3.2.1. Market size and forecast

Chapter: 7 STDS DIAGNOSIS MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends, growth factors and opportunities
7.2.2. North America STDs diagnosis market by country
7.2.2.1. U.S. STDs diagnosis market
7.2.2.1.1. U.S. market by disease type
7.2.2.1.2. U.S. market by location of diagnosis
7.2.2.1.3. U.S. market by device type
7.2.2.2. Canada STDs diagnosis market
7.2.2.2.1. Canada market by disease type
7.2.2.2.2. Canada market by location of diagnosis
7.2.2.2.3. Canada market by device type
7.2.2.3. Mexico STDs diagnosis market
7.2.2.3.1. Mexico market by disease type
7.2.2.3.2. Mexico market by location of diagnosis
7.2.2.3.3. Mexico market by device type
7.2.3. North America STDs diagnosis market by disease type
7.2.4. North America STDs diagnosis market by location of diagnosis
7.2.5. North America STDs diagnosis market by device type
7.3. EUROPE
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Europe STDs diagnosis market by country
7.3.2.1. Germany STDs diagnosis market
7.3.2.1.1. Germany market by disease type
7.3.2.1.2. Germany market by location of diagnosis
7.3.2.1.3. Germany market by device type
7.3.2.2. France STDs diagnosis market
7.3.2.2.1. France market by disease type
7.3.2.2.2. France market by location of diagnosis
7.3.2.2.3. France market by device type
7.3.2.3. UK STDs diagnosis market
7.3.2.3.1. UK market by disease type
7.3.2.3.2. UK market by location of diagnosis
7.3.2.3.3. UK market by device type
7.3.2.4. Italy STDs diagnosis market
7.3.2.4.1. Italy market by disease type
7.3.2.4.2. Italy market by location of diagnosis
7.3.2.4.3. Italy market by device type
7.3.2.5. Spain STDs diagnosis market
7.3.2.5.1. Spain market by disease type
7.3.2.5.2. Spain market by location of diagnosis
7.3.2.5.3. Spain market by device type
7.3.2.6. Rest of Europe STDs diagnosis market
7.3.2.6.1. Rest of Europe market by disease type
7.3.2.6.2. Rest of Europe market by location of diagnosis
7.3.2.6.3. Rest of Europe market by device type
7.3.3. Europe STDs diagnosis market by disease type
7.3.4. Europe STDs diagnosis market by location of diagnosis
7.3.5. Europe STDs diagnosis market by device type
7.4. ASIA-PACIFIC
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Asia-Pacific STDs diagnosis market by country
7.4.2.1. Japan STDs diagnosis market
7.4.2.1.1. Japan market by disease type
7.4.2.1.2. Japan market by location of diagnosis
7.4.2.1.3. Japan market by device type
7.4.2.2. China STDs diagnosis market
7.4.2.2.1. China market by disease type
7.4.2.2.2. China market by location of diagnosis
7.4.2.2.3. China market by device type
7.4.2.3. Australia STDs diagnosis market
7.4.2.3.1. Australia market by disease type
7.4.2.3.2. Australia market by location of diagnosis
7.4.2.3.3. Australia market by device type
7.4.2.4. India STDs diagnosis market
7.4.2.4.1. India market by disease type
7.4.2.4.2. India market by location of diagnosis
7.4.2.4.3. India market by device type
7.4.2.5. South Korea STDs diagnosis market
7.4.2.5.1. South Korea market by disease type
7.4.2.5.2. South Korea market by location of diagnosis
7.4.2.5.3. South Korea market by device type
7.4.2.6. Rest of Asia-Pacific STDs diagnosis market
7.4.2.6.1. Rest of Asia-Pacific market by disease type
7.4.2.6.2. Rest of Asia-Pacific market by location of diagnosis
7.4.2.6.3. Rest of Asia-Pacific market by device type
7.4.3. Asia-Pacific STDs diagnosis market by disease type
7.4.4. Asia-Pacific STDs diagnosis market by location of diagnosis
7.4.5. Asia-Pacific STDs diagnosis market by device type
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. LAMEA STDs diagnosis market by country
7.5.2.1. Brazil STDs diagnosis market
7.5.2.1.1. Brazil market by disease type
7.5.2.1.2. Brazil market by location of diagnosis
7.5.2.1.3. Brazil market by device type
7.5.2.2. Saudi Arabia STDs diagnosis market
7.5.2.2.1. Saudi Arabia market by disease type
7.5.2.2.2. Saudi Arabia market by location of diagnosis
7.5.2.2.3. Saudi Arabia market by device type
7.5.2.3. South Africa STDs diagnosis market
7.5.2.3.1. South Africa market by disease type
7.5.2.3.2. South Africa market by location of diagnosis
7.5.2.3.3. South Africa market by device type
7.5.2.4. Rest of LAMEA STDs diagnosis market
7.5.2.4.1. Rest of LAMEA market by disease type
7.5.2.4.2. Rest of LAMEA market by location of diagnosis
7.5.2.4.3. Rest of LAMEA market by device type
7.5.3. LAMEA STDs diagnosis market by disease type
7.5.4. LAMEA STDs diagnosis market by location of diagnosis
7.5.5. LAMEA STDs diagnosis market by device type

Chapter: 8 COMPANY PROFILES

8.1. F. HOFFMANN-LA ROCHE AG
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. BIOMÉRIEUX SA
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. HOLOGIC, INC.
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. BECTON DICKINSON & COMPANY
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. CEPHEID, INC.
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. DANAHER CORPORATION
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. AFFYMETRIX, INC.
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. ALERE INC.
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. ABBOTT LABORATORIES
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. DIASORIN S.P.A.
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
World STDs Diagnosis Market- Opportunities and Forecasts, 2014 - 2022

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo